Biomarin Pharmaceutical (BMRN) Enterprise Value (2009 - 2026)
Biomarin Pharmaceutical's Enterprise Value came in at $10.2 billion for Q2 2026, up 11.8% from $9.12 billion a year earlier and up 17.3% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Enterprise Value (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported Enterprise Value of $4.94 billion, down 14.6% year-over-year; for FY2025, it was $9.87 billion, down 13.4% from FY2024.
- Enterprise Value has declined in each of the last three years, with a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $11.4 billion in FY2024 (-33.4%), $17.11 billion in FY2023 (-4.9%), $17.98 billion in FY2022 (+18.0%) and $15.23 billion in FY2021 (+2.4%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q1 2025.
- Year-over-year, Enterprise Value increased in 1 of the last eight quarters, with an average decline of 21.3%.
- The fastest year-over-year change in Enterprise Value over five years came in Q1 2023 (growth of 29.5%), and the weakest in Q2 2025 (a decline of 36.9%).
- Business Quant data shows BMRN's Enterprise Value at $8.7 billion (Q1 2026), $9.87 billion (Q4 2025) and $8.93 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.20 Bn |
| Mar 31, 2026 | 8.70 Bn |
| Dec 31, 2025 | 9.87 Bn |
| Sep 30, 2025 | 8.93 Bn |
| Jun 30, 2025 | 9.12 Bn |
| Mar 31, 2025 | 12.28 Bn |
| Dec 31, 2024 | 11.40 Bn |
| Sep 30, 2024 | 12.46 Bn |
| Jun 30, 2024 | 14.45 Bn |
| Mar 31, 2024 | 15.53 Bn |
| Dec 31, 2023 | 17.11 Bn |
| Sep 30, 2023 | 15.54 Bn |
| Jun 30, 2023 | 15.14 Bn |
| Mar 31, 2023 | 17.09 Bn |
| Dec 31, 2022 | 17.98 Bn |
| Sep 30, 2022 | 14.48 Bn |
| Jun 30, 2022 | 14.26 Bn |
| Mar 31, 2022 | 13.20 Bn |
| Dec 31, 2021 | 15.23 Bn |
| Sep 30, 2021 | 13.11 Bn |
API Access
Biomarin Pharmaceutical Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();